Jim Cahill

Jim Cahill is a former staff writer for Insulin Nation and a former editor of Type 2 nation.
Uncategorized

National Clinical Care Commission: “Laser-like” Review of Diabetes Programs, Policies

Legislation to improve diabetic health, whether through better management of the government’s resources or to appropriate funds to support public…

Read More »
Uncategorized

@Reality DMTV

You, too, can elevate your daily work of “taking care of the sugars” to the elite class. You can join…

Read More »
Living

Tax Hikes For Medical Technology Industry Take Effect

On the first of the year, an excise tax on medical device makers resumed after two-year hiatus.

Read More »
Treatment

Why is Some Insulin Available Over the Counter?

To answer this, we walk you through the history of drug regulation in the U.S.

Read More »
Living

How the Trump Immigration Ban Might Affect Diabetes Research

We examine the cases against the executive order barring immigrants and refugees from seven countries.

Read More »
Living

Why People are Skeptical of Your Diabetes Service Dog

Fly-by-night businesses offer service dog documentation with just a few mouse-clicks.

Read More »
Living

Price-fixing Alleged in Lawsuit Against Insulin Makers

We provide an analysis of the legal arguments in the customer-centered complaint.

Read More »
Living

When the School Nurse Won’t Help with Your Child’s Pump

A Virginia mother lodges complaints with the U.S. Department of Education about what she says is inadequate diabetes care during…

Read More »
Living

Seeking Blame in Morgan Angerbauer’s DKA Death

The fault may lie in the private prison system.

Read More »
Research

How the 21st Century Cures Act Will Change Diabetes Care

The new law is designed to streamline clinical trials and encourage investment in new treatments.

Read More »
Treatment

The U.S. Can’t Afford Not to Have a Cure for Diabetes

Spending on diabetes care takes up a significant slice of the GDP, and that slice will only get bigger.

Read More »
Living

Are PBMs Driving Up The Price of Insulin?

An overview of prescription benefit managers, which drug companies fear now, but consumer advocates might grow to fear.

Read More »
Treatment

California Drug-Pricing Control Referendum Defeated

Advocates cited insulin prices as a major reason for why the measure was needed.

Read More »
Research

Dual-Hormone ILet Poised to Begin FDA Testing in 2017

If successful, the system would be the first to use both glucagon and insulin to make it to market.

Read More »
Treatment

UK Petition Asks Government to Pay for Costs of CGMs

The petition has been led by a member of Parliament who has Type 1 diabetes.

Read More »
Treatment

Metformin – a Misunderstood Drug?

A new study suggests scientists may have misunderstood how the drug works in the human body.

Read More »
Treatment

FDA Board Suggests Warning for Gliptins

The drugs, used to stimulate insulin production, could cause problems for those at risk of heart disease.

Read More »
Treatment

Lawsuits Allege Invokana, SGLT2 Drugs Unsafe

The FDA is also tracking possible side effects of this new class of Type 2 diabetes drugs.

Read More »
Treatment

A Glimpse Into Your Next Retinopathy Exam

A man with Type 2 diabetes walks readers through the process, with a few drops of humor.

Read More »
Living

Cashier with Diabetes Illegally Fired for Treating a Low

A court forces Dollar General Store to pay $278,000 in damages to a worker who drank orange juice on the…

Read More »
Back to top button